Skip to content

Therapy for children with movement disorders - reFit Gamo Home - Digital therapy for children at home - Galileo Vibration Therapy

Therapy for children with movement disorders - reFit Gamo Home - Digital therapy for children at home - Galileo Vibration Therapy - Gamo Home

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037315
Enrollment
40
Registered
2025-07-07
Start date
2021-08-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G80

Interventions

Group 1: Therapy with Gamo on an outpatient basis in the clinic or continuous teletherapeutic therapy at home Group 2: Therapy with Gamo at home with teletherapeutic support at least once a week

Sponsors

iSPZ Hauner
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 17 Years

Inclusion criteria

Inclusion criteria: - Children aged 6 and over who receive continuous medical and therapeutic care at the iSPZ Hauner. - Consent of parents and, if applicable, patients to participate in the pilot study - Indication for physiotherapy

Exclusion criteria

Exclusion criteria: - Lack of cognitive ability to actively participate in Gamo Home / VT therapy - Lack of willingness/ability of parents to engage with technical equipment equipment (Gamo, Galileo, Internet) - Acute inflammation of the musculoskeletal/ligamentous/articular system - Unclear swelling/pain of the musculoskeletal/ligamentous/articular system - Acute thrombosis - Pathological bone fractures within the last 6 months - Bisphosphonate therapy - Bone surgery within the last 4 months - Muscle operations within the last 6 weeks - Known stone disease of the biliary tract and abl. urinary tract - Therapy-resistant epilepsy as a comorbidity - Pregnancy cannot be ruled out with certainty - Artificial knee/hip joints

Design outcomes

Primary

MeasureTime frame
Gross motor function measure (GMFM) after 6 weeks of therapy Gross motor function measure (GMFM) is a clinical instrument that was developed to assess changes in gross motor function in children with cerebral palsy both in clinical both in clinical practice and for research purposes.

Secondary

MeasureTime frame
Usage data and automatic feedback During therapy, usage data from reFit Gamo Home is recorded throughout the course of the study. This includes data on the frequency and duration of use, the course of use and also data on the success of the therapy. Subjective data on gaming success (virtual game coins collected) as well as objective measurement data (progression of movement volumes; movement intensity) are recorded here. During therapy at home, parents and patients receive daily questions from the computer system in which they can give their subjective assessment of the therapy and the organizational and technical process on a scale of 0-10 (100 units) (Did you enjoy it today? How exhausting was playing for you today? How reliably was Gamo usable this session?) Questions are also regularly asked automatically about side effects (Have your child experienced side effects so far?), integration into everyday life, possible other users (Was the system only used by the participating patient?) and long-term motivation (How long would it make sense for your child to continue therapy?).

Countries

Germany

Contacts

Public ContactLorenz Kiwull

iSPZ Hauner

kiwull@serious-gaming.net+49?15165459353?

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026